PositiveID (PSID) to Launch Clinical Trial of Its Easy Check Non-Invasive Breath Glucose Detection Device This Month

DELRAY BEACH, Fla., Jan. 5, 2012 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID" or "Company") (OTCBB:PSID), a developer of medical technologies for diabetes management, announced today it will launch the first clinical trial of its Easy Check™ non-invasive breath glucose detection device for people with diabetes later this month. The clinical trial will initially focus on people with type 2 diabetes. Easy Check would eliminate a patient's need to prick his or her finger multiple times per day to get a blood sugar reading.